(1)
Kumar, A. S.; Samuel, V. Cost-Effectiveness of Co-Amoxiclav Versus Clindamycinin the Treatment of Uncomplicated Soft Tissue Infections in a Tertiary Care Hospital. health 2025, 1, 15-22.